ARCHIVES

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

This article is from The Cancer Letter archive.

Vol. 38 No. 31 | August 3, 2012

Download PDF Visit The Full Archive

Related Articles

Prostatectomy Lowers Death Risk Compared to Watchful Waiting

April 29, 2011

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

Eugenia Calle, 57, ACS Epidemiologist, Found Dead at Home; Murder Suspect Arrested

February 20, 2009

Estrogen Can Benefit Women With Metastatic Breast Cancer

January 30, 2009